Biosimilars Versus Biologics – How About Both?

Continuing the theme from our previous blog on the benefits of competition among prescription drugs, we now turn to another type of competition: the role of biosimilars in lowering the escalating prices of biologic drugs.

Learn More >

PCMA Unveils Three-Part Policy Platform to Reduce Prescription Drug Costs

For America’s pharmacy benefit managers, PBMs, our core mission is to increase access to affordable prescription drugs for all Americans.

Read More >

Competition in the Prescription Drug Market

To analyze the role public policy plays in this challenge, host JC Scott talks with Lauren Aronson, health policy expert and Executive Director of the Campaign for Sustainable Rx Drug Pricing (CSRxP).

Listen Now >

Video Series Featuring Employers Discussing the Value of PBMs

PCMA released a series of videos showcasing the value PBMs provide employers.

Learn More

PBM Industry Principles

PBMs have distinct business processes that differentiate them in the market, but PBMs also adhere to stringent accreditation standards, the terms of negotiated contracts, and legal requirements.

Learn More

PCMA Latest News

PCMA Smart Briefs

PBMs are working to help 266 million patients get the prescriptions they need during the pandemic.
Better access. Better Cost. Better Health.

PCMA’s Commitment to Diversity, Inclusion and Equity

PCMA believes that organizational and employee success require a diverse, equitable, and inclusive workforce and a culture that embraces and encourages different perspectives. We recognize the inherent value in employing a workforce with a range of experiences and it is our commitment to embrace every person’s uniqueness and to provide a professional work environment where everyone is welcome and treated with dignity and respect.

PCMA has signed on to the CEO Action for Diversity & Inclusion™ pledge. Read more here.

Join the Conversation

Stay Connected with PCMA!